Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

10.92
+0.38003.61%
Post-market: 10.91-0.0100-0.09%19:58 EST
Volume:975.07K
Turnover:10.52M
Market Cap:573.52M
PE:8.08
High:10.96
Open:10.65
Low:10.40
Close:10.54
52wk High:14.06
52wk Low:4.02
Shares:52.52M
Float Shares:51.26M
Volume Ratio:1.44
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.35
EPS(LYR):-3.5962
ROE:13.92%
ROA:5.27%
PB:0.98
PE(LYR):-3.04

Loading ...

Emergent BioSolutions: Will Provide Reporting to Oag for a Period of Three Years

THOMSON REUTERS
·
Jan 16

N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading

Dow Jones
·
Jan 16

Former Emergent BioSolutions CEO sued by NY AG for insider trading

TIPRANKS
·
Jan 16

Emergent BioSolutions outlines transformation and financial guidance at conference

TIPRANKS
·
Jan 15

FDA Approves New Carrying Case for Emergent BioSolutions' OTC NARCAN Nasal Spray

Reuters
·
Jan 14

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for Narcan® Nasal Spray to Be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

THOMSON REUTERS
·
Jan 14

H.C. Wainwright Remains a Buy on Emergent Biosolutions (EBS)

TIPRANKS
·
Jan 13

Emergent BioSolutions Announces $100 Million Voluntary Term Loan Prepayment, Reducing Total Debt by 32%

Reuters
·
Jan 12

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward Its Multi-Year Transformation

THOMSON REUTERS
·
Jan 12

BRIEF-Emergent Bio- Receives $21.5 Mln Order From U.S. Department Of War To Supply Biothrax In 2026

Reuters
·
Jan 09

Emergent BioSolutions Inc - Receives $21.5 Mln Order From U.S. Department of War to Supply Biothrax in 2026

THOMSON REUTERS
·
Jan 09

Emergent BioSolutions Receives $21.5 Million Order to Supply Anthrax Vaccine to U.S. Department of War

Reuters
·
Jan 09

Emergent BioSolutions: Strategic Infectious Disease Positioning and Countermeasure Demand Support Buy Rating and $15 Target

TIPRANKS
·
Jan 08

Emergent BioSolutions Partners with PANTHER to Support Africa CDC-Led Mpox Study

Reuters
·
Jan 08

Emergent BioSolutions and Panther Announce Agreement to Support the Continuation of the Africa Cdc-Led Mpox Study in Africa

THOMSON REUTERS
·
Jan 08

Emergent BioSolutions Inc - Africa Cdc and Panther to Extend Study to Uganda

THOMSON REUTERS
·
Jan 08

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Dec 16, 2025

FDA Approves Emergent BioSolutions Winnipeg Facility for Raxibacumab Manufacturing

Reuters
·
Dec 12, 2025

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of Raxibacumab at Its Winnipeg, Canada Site

THOMSON REUTERS
·
Dec 12, 2025

Director Ronald Richard Sells Common Shares of Emergent BioSolutions Inc

Reuters
·
Dec 10, 2025